SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities.
about
Principles of interleukin (IL)-6-type cytokine signalling and its regulationCullin 5 regulates Dab1 protein levels and neuron positioning during cortical developmentNegative regulation of cytokine signaling and immune responses by SOCS proteinsSOCS3: An essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokinesThe biology and mechanism of action of suppressor of cytokine signaling 3The role of suppressors of cytokine signalling in human neoplasmsStructure of the SOCS4-ElonginB/C Complex Reveals a Distinct SOCS Box Interface and the Molecular Basis for SOCS-Dependent EGFR DegradationSOCS3 binds specific receptor–JAK complexes to control cytokine signaling by direct kinase inhibitionSHP2 and SOCS3 contribute to Tyr-759-dependent attenuation of interleukin-6 signaling through gp130Suppressor of cytokine signaling 6 associates with KIT and regulates KIT receptor signalingOncogenic mechanisms of the Helicobacter pylori CagA proteinHelicobacter pylori CagA: a new paradigm for bacterial carcinogenesisProtein tyrosine phosphatases in the JAK/STAT pathwayAssociation of CagA EPIYA-D or EPIYA-C phosphorylation sites with peptic ulcer and gastric cancer risks: A meta-analysis.Sequence specificity of SHP-1 and SHP-2 Src homology 2 domains. Critical roles of residues beyond the pY+3 position.Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites.Mechanism of attenuation of leptin signaling under chronic ligand stimulation.Leptin revisited: its mechanism of action and potential for treating diabetes.Elucidating the crosstalk mechanism between IFN-gamma and IL-6 via mathematical modelling.Characterization of CagA variable region of Helicobacter pylori isolates from Chinese patientsIL-6 mediates the susceptibility of glycoprotein 130 hypermorphs to Toxoplasma gondiiRegulation of TLR signaling and inflammation by SOCS family proteins.Suppressor of cytokine signaling 3 inhibits breast tumor kinase activation of STAT3.Shp-2 contributes to anti-RSV activity in human pulmonary alveolar epithelial cells by interfering with the IFN-α-induced Jak/Stat1 pathwaySOCS regulation of the JAK/STAT signalling pathway.Failed interleukin-6 signal transduction in murine sepsis: attenuation of hepatic glycoprotein 130 phosphorylation.Molecular and neural mediators of leptin actionInhibition of IL-6 family cytokines by SOCS3.H. pylori infection, inflammation and gastric cancer.SOCS proteins in regulation of receptor tyrosine kinase signaling.Role of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression.Analysis of SOCS-3 promoter responses to interferon gamma.Introduction: History of SH2 Domains and Their Applications.SOCS3 revisited: a broad regulator of disease, now ready for therapeutic use?Negative Regulators of JAK/STAT Signaling in Rheumatoid Arthritis and Osteoarthritis.JAK2 and SHP2 reciprocally regulate tyrosine phosphorylation and stability of proapoptotic protein ASK1.A novel conserved phosphotyrosine motif in the Drosophila fibroblast growth factor signaling adaptor Dof with a redundant role in signal transmission.Oncostatin M receptor-mediated signal transduction is negatively regulated by SOCS3 through a receptor tyrosine-independent mechanism.Simple method for determination of the number of Helicobacter pylori CagA variable-region EPIYA tyrosine phosphorylation motifs by PCRTyrosine phosphorylation of CagA from Chinese Helicobacter pylori isolates in AGS gastric epithelial cells.
P2860
Q24530173-6DDB6830-0DB4-495D-8992-CB6873D068FFQ24672124-7EBBD396-D314-42D8-802D-D20F0D6F49EFQ24816896-0000A909-3ECD-4B3B-A270-5AA402B70091Q26853718-F568AC39-1B98-4D0A-9D02-73B75EABDDFCQ27003933-B8D2EDD1-82AF-4F9F-98A0-4C838FF868BDQ27026783-A7549125-3CD0-43CB-B260-AEF64A70DF64Q27649020-02ED581D-696D-4BB4-87FC-C46FB3D61968Q27676669-CA16BA9D-7D4B-4F80-B581-2351DBA48B01Q28211408-C690E43F-3DEA-481E-B0BE-0C43A7A23F66Q28237281-C877395D-01FF-4101-AE9A-46DC0D4B6EA8Q28280246-69A70DF9-58C3-4925-BFF0-FDFB93199248Q28287897-8101F052-E4E7-4733-B07D-E31731E011F1Q28646447-8476DB96-D779-4720-A50E-2ECB3370E0D7Q30234657-5A8D8C8E-1589-4A2E-B7C5-EBEC3181669BQ33243531-D7BB8D5E-65DD-4542-8A10-30D33F241B17Q33292319-A76D628D-3C6A-412F-B3CF-B4B02941B80FQ33522778-2E729B78-2492-42D6-9E2B-5AE41C2C7D23Q33602487-5920124A-77A4-4B08-AABB-89030BF7B826Q34577551-EC289C10-52C7-4C7A-BEE4-5F42B7AEF4F4Q34604754-302E5764-A6AA-470A-B375-F65B71D7F497Q35058854-BE7C8AB1-F0DB-4895-9E9B-F7421D288983Q35630518-85592E7B-1564-4520-A06B-3EB666CFA380Q36033134-B58AE96E-F1E4-44EA-B9C1-8FF03421B3A5Q36125395-3A60544D-A780-4AE4-9560-2221901385D0Q37003892-29DAA2B4-F385-4A31-8AA8-40A77358C1EFQ37163238-841912C8-DE4C-494C-8BD1-0322AEA0A3FFQ37172273-E1D3CD84-C52C-4E5C-8F85-EDD662B7456EQ37676036-212EBD84-0322-419E-A1EC-DA1537F81E1CQ38190020-A6AC2D1A-C226-4117-8AAB-0293742536FFQ38202542-D91EECD9-BDBB-4642-B382-66B5E3AFD3C6Q38216732-42DA5778-D310-4406-AFC5-0BE1AC7766A3Q38345570-D7EE124F-5A1D-403C-919D-EF707ECBAADEQ38770008-98ADB979-A8BB-4AEC-92C1-357D5A0619F2Q38823319-F2CCF1E7-BAA3-420D-9301-4E29BB67DDDCQ39154718-111A179D-AA3E-47C5-8430-6613F2B12C6CQ39872760-CFF27A14-BA53-41D3-8A9B-392397013B10Q39897837-C0C6D426-5798-4BEB-A86E-E37551F2A26FQ40320402-0EF8529B-0A8A-4207-90CF-90FB860089C2Q41040149-09558378-AA66-446E-81FA-D985F5B3BB74Q41040797-F0554278-AD4E-4EEE-8C2D-BD9E86612C64
P2860
SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
SH2 domains from suppressor of ...... similar binding specificities.
@ast
SH2 domains from suppressor of ...... similar binding specificities.
@en
type
label
SH2 domains from suppressor of ...... similar binding specificities.
@ast
SH2 domains from suppressor of ...... similar binding specificities.
@en
prefLabel
SH2 domains from suppressor of ...... similar binding specificities.
@ast
SH2 domains from suppressor of ...... similar binding specificities.
@en
P2093
P50
P356
P1433
P1476
SH2 domains from suppressor of ...... similar binding specificities.
@en
P2093
Andrew Nash
Louis J Fabri
Manuel Baca
P304
P356
10.1021/BI0259507
P407
P577
2002-07-01T00:00:00Z